These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Luteal phase support for assisted reproduction cycles. van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Baker VL; Jones CA; Doody K; Foulk R; Yee B; Adamson GD; Cometti B; DeVane G; Hubert G; Trevisan S; Hoehler F; Jones C; Soules M Hum Reprod; 2014 Oct; 29(10):2212-20. PubMed ID: 25100106 [TBL] [Abstract][Full Text] [Related]
4. Luteal phase support in assisted reproduction cycles. Daya S; Gunby J Cochrane Database Syst Rev; 2004; (3):CD004830. PubMed ID: 15266541 [TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Luteal phase support in assisted reproduction cycles. Daya S; Gunby JL Cochrane Database Syst Rev; 2008 Jul; (3):CD004830. PubMed ID: 18646113 [TBL] [Abstract][Full Text] [Related]
6. Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8. Michnova L; Dostal J; Kudela M; Hamal P; Langova K Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):86-91. PubMed ID: 28323291 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. Kleinstein J; Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631 [TBL] [Abstract][Full Text] [Related]
8. Luteal phase support in in vitro fertilization. Yanushpolsky EH Semin Reprod Med; 2015 Mar; 33(2):118-27. PubMed ID: 25734349 [TBL] [Abstract][Full Text] [Related]
9. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration. Friedler S; Raziel A; Schachter M; Strassburger D; Bukovsky I; Ron-El R Hum Reprod; 1999 Aug; 14(8):1944-8. PubMed ID: 10438404 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of an optimal luteal phase support protocol in IVF. Ludwig M; Diedrich K Acta Obstet Gynecol Scand; 2001 May; 80(5):452-66. PubMed ID: 11328224 [TBL] [Abstract][Full Text] [Related]
11. Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial. Elgindy EA; Sibai H; Mostafa MI; Gibreel A; Darwish E; Maghraby H Hum Reprod; 2018 Jun; 33(6):1079-1086. PubMed ID: 29562260 [TBL] [Abstract][Full Text] [Related]
12. Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China. Chi H; Li R; Qiao J; Chen X; Wang X; Hao G; Wu Q; Cao Y; Cai L; Ye H; Zhu Y; Wang S; Zhang X; Zhang C; Zhang Y; Lv Q; Sun Y; Li H; Huang X; Wang F Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():100-105. PubMed ID: 31035117 [TBL] [Abstract][Full Text] [Related]
13. Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone. Ho CH; Chen SU; Peng FS; Chang CY; Yang YS J Chin Med Assoc; 2008 Aug; 71(8):386-91. PubMed ID: 18772117 [TBL] [Abstract][Full Text] [Related]
14. Luteal support with vaginal micronized progesterone gel in assisted reproduction. Penzias AS; Alper MM Reprod Biomed Online; 2003; 6(3):287-95. PubMed ID: 12735861 [TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles. Bar Hava I; Blueshtein M; Ganer Herman H; Omer Y; Ben David G Fertil Steril; 2017 Jan; 107(1):130-135.e1. PubMed ID: 28228316 [TBL] [Abstract][Full Text] [Related]
16. [GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome]. Guivarc'h-Levêque A; Jaffré F; Homer L; Moy L; Priou G; Colleu D; Denis I; Arvis P Gynecol Obstet Fertil; 2013 Sep; 41(9):511-4. PubMed ID: 23972925 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials. Doblinger J; Cometti B; Trevisan S; Griesinger G PLoS One; 2016; 11(3):e0151388. PubMed ID: 26991890 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Lockwood G; Griesinger G; Cometti B; Fertil Steril; 2014 Jan; 101(1):112-119.e3. PubMed ID: 24140033 [TBL] [Abstract][Full Text] [Related]
19. Greater implantation and pregnancy rates with vaginal progesterone in intracytoplasmic sperm injection but not in in vitro fertilization cycles: a retrospective study. Manno M; Marchesan E; Cicutto D; Zadro D; Favretti C; Tomei F Fertil Steril; 2005 May; 83(5):1391-6. PubMed ID: 15866574 [TBL] [Abstract][Full Text] [Related]
20. Luteal phase support in assisted reproductive technology. Pabuccu R; Akar ME Curr Opin Obstet Gynecol; 2005 Jun; 17(3):277-81. PubMed ID: 15870562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]